Analysts' outlook on Abbott Laboratories remains steady, des...
Analysts' outlook on Abbott Laboratories remains steady, despite projected slowdown in revenue growth to 4.6% annually until 2024, well below its historical 7.9% p.a. growth and slower than industry peers.
![](https://pubimg-10000538.picsh.myqcloud.com/202205090000023942fed5b24e5.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment